New York City

Longer, Fuller Lashes

0
4 January 2010

Last year, the FDA approved the prescription drug Latisse for treatment of hypotrichosis. Hypotrichosis is a condition of abnormal hair growth, usually characterized by lack of hair where “normal” people grow hair. (Not to be confused with alopecia, which is characterized by the loss of hair where hair formerly existed.) For suffers nationwide, this meant the growth of fuller, thicker, longer hair in places they formerly had none – places that piqued the interest of beauty product lovers hoping to plump up their eyelashes.

lashes before and after latisse

In the clinical study, 78% of patients experienced remarkable increases in fullness, length and darker colored lashes. The drawbacks, because of course there are some, are as follows: Eye itching and eye redness are the most common side effects during the 16 week recommended use of the product. And most people we know experienced at least some of this during use. Increased pigmentation on the eye lids may not be permanent, but likely occurs during use. There is a risk for hair growth where ever the solution is applied (gross), but this can be prevented with proper application.

Anyway, there are a whole list of precautions, side effects, etc. that you can find here. Otherwise, it pretty much works wonders. Visit the Latisse website to see the before and after lash pics like that above from the 16 week trial study.


Daily Sales Email, or Subscribed to our RSS Feed? Don't miss a Sale!



Posted by Emma Dinzebach at 12:00 AM
bargain news , BEAUTY | Trackback |

Leave a Reply

Your email address will not be published. Required fields are marked *

Follow us on FacebookFollow us on TwitterFollow us on PinterestFollow us on FoursquareGoogle PlusSubscribe to our feed

Know something we don't? Email us
at [email protected]

Submit your email so you never miss
another NEW YORK SAMPLE SALE


If you didn't buy anything at a sample sale in 2017, was it because:

View Results

Loading ... Loading ...

Twitter: TheStylishCity



Copyright © 2017 TheStylishCity,
a Graybar Group LLC company
Advertise With Us
Organically grown readership
Connect with us

Web Statistics